Kumar brings over 25 years of experience in the healthcare, pharmaceutical, and medical technology sectors. His expertise includes strategy...

"We have been serving Indian patients for 40 years, trained physicians for years. Since 2011, we've ramped up our research and development ...

Medtronic has expanded its Medtronic Engineering and Innovation Center (MEIC) in Hyderabad, India. The state-of-the-art R&D center, part of...

US medtech major Medtronic on Thursday announced an investment of Rs 3,000 crore to expand the Medtronic Engineering & Innovation Center (M...

In this role, Blackwell will be responsible for sales, marketing, and commercial operations of Medtronic’s India business.

Medtronic, the medical device maker plans to spin off its patient monitoring and respiratory interventions businesses into a new company, j...

During the virtual meeting, Sandhu also highlighted that the knowledge and education partnership is a key pillar of the India US relationsh...

The centre will serve as a global hub for development, testing and qualification for some of the most advanced and innovative medical techn...

India should incentivise manufacturing companies including multinationals, instead of taking a protectionist stance, if it plans to grow in...

The Irish medical technology firm, known for inventing battery-powered pacemaker, offers medical products to treat over 70 health condition...

The voluntary recall is not expected to impact Medtronic’s ‘Diabetes Group’ revenue growth in the second quarter or the full fiscal year, s...

The companies sought to withdraw Abbott’s Xience Alpine and Absorb, and Medtronic’s Resolute Onyx stents after NPPA slashed their prices by...

The company plans to offer high priced devices like stents, heart valves and pacemakers on monthly instalments to low-income, underserved p...

The collaboration will leverage on a technology platform developed by Medtronic, supported with clinical insight from Apollo.

Medtronic Inc's Indian arm said it is looking at over 20 per cent growth in the South Asian region for the current financial year.

This is still a small piece of India, but if they can afford it why don’t they get it? The answer revolves around three reasons, Ishrak sai...

Patients can buy products such as stents, pacemakers and defibrillators priced between Rs 20,000 and Rs 5 lakh.